ArticlePharmacoEconomics - open2023

A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America.

Aaron Winn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.